eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0028756|morbid obesity |
| Sentences | 9 |
| PubMedID- PMC3363271 | There is an alteration in cgmp metabolism in nafld in patients with morbid obesity. |
| PubMedID- 23431426 | morbid obesity is strongly associated with nonalcoholic fatty liver disease (nafld) which is one of the most common causes of chronic liver disease worldwide. |
| PubMedID- 23304464 | nafld is associated with morbid obesity, type 2 diabetes, and hyperlipidaemia; however, excess alcohol intake is still the main cause of fatty liver disease. |
| PubMedID- 20492695 | Visceral adipose tissue samples were obtained from 10 patients diagnosed with morbid obesity and one of the nafld spectrum diseases (n = 10) and nine lean patients with normal liver biopsies (n = 9). |
| PubMedID- 25591123 | morbid obesity is strongly associated with nonalcoholic fatty liver disease (nafld), which is one of the most common causes of chronic liver disease worldwide. |
| PubMedID- 22648049 | * arfi differentiates nafld from nash in patients with morbid obesity. |
| PubMedID- 24737534 | Background: morbid obesity is strongly associated with nonalcoholic fatty liver disease. |
| PubMedID- 21499110 | Background: liver biopsy is considered as the gold standard for assessing nonalcoholic fatty liver disease (nafld) histologic lesions in patients with morbid obesity. |
| PubMedID- 24763757 | In conclusion, a proportion of nafld patients without morbid obesity, which is similar of that of matched subjects from the general population without ultrasonographic steatosis, is at high risk for osas with excessive daytime sleepiness, as detected by bq and ess combined positivity. |
Page: 1